BNP Paribas Asset Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-269,518
| Closed | -$26.8M | – | 875 |
|
|
2019
Q3 | $26.8M | Sell |
269,518
-274,285
| -50% | -$26.1M | 0.21% | 140 |
|
|
2019
Q2 | $50.3M | Sell |
543,803
-37,950
| -7% | -$3.6M | 0.41% | 57 |
|
|
2019
Q1 | $54.9M | Sell |
581,753
-112,217
| -16% | -$9.81M | 0.46% | 41 |
|
|
2018
Q4 | $43.3M | Buy |
693,970
+290,006
| +72% | +$21.4M | 0.4% | 50 |
|
|
2018
Q3 | $36.2M | Buy |
403,964
+23,455
| +6% | +$2.07M | 0.28% | 93 |
|
|
2018
Q2 | $30.2M | Sell |
380,509
-725,499
| -66% | -$60.2M | 0.25% | 101 |
|
|
2018
Q1 | $98.7M | Sell |
1,106,008
-76,441
| -6% | -$7.34M | 0.83% | 12 |
|
|
2017
Q4 | $123M | Buy |
1,182,449
+149,511
| +14% | +$16.9M | 1.05% | 10 |
|
|
2017
Q3 | $151M | Sell |
1,032,938
-18,888
| -2% | -$2.57M | 1.27% | 7 |
|
|
2017
Q2 | $137M | Sell |
1,051,826
-36,284
| -3% | -$4.45M | 1.21% | 7 |
|
|
2017
Q1 | $135M | Buy |
1,088,110
+217,055
| +25% | +$26M | 1.24% | 6 |
|
|
2016
Q4 | $101M | Buy |
871,055
+49,813
| +6% | +$5.55M | 0.97% | 6 |
|
|
2016
Q3 | $85.8M | Sell |
821,242
-108,098
| -12% | -$11.7M | 0.73% | 16 |
|
|
2016
Q2 | $91.7M | Buy |
929,340
+135,280
| +17% | +$14M | 0.77% | 13 |
|
|
2016
Q1 | $79.5M | Sell |
794,060
-49,025
| -6% | -$5.05M | 0.67% | 21 |
|
|
2015
Q4 | $101M | Buy |
843,085
+585
| +0.1% | +$67.7K | 0.86% | 10 |
|
|
2015
Q3 | $91.1M | Buy |
842,500
+54,079
| +7% | +$6.71M | 0.8% | 10 |
|
|
2015
Q2 | $91.2M | Sell |
788,421
-98,680
| -11% | -$11.3M | 0.74% | 14 |
|
|
2015
Q1 | $102M | Sell |
887,101
-233,500
| -21% | -$27.9M | 0.78% | 11 |
|
|
2014
Q4 | $125M | Buy |
1,120,601
+40,382
| +4% | +$4.26M | 1.01% | 5 |
|
|
2014
Q3 | $102M | Buy |
1,080,219
+97,588
| +10% | +$8.81M | 0.83% | 16 |
|
|
2014
Q2 | $84.4M | Buy |
982,631
+268,909
| +38% | +$20.4M | 0.65% | 23 |
|
|
2014
Q1 | $49.8M | Sell |
713,722
-618,034
| -46% | -$48.9M | 0.38% | 73 |
|
|
2013
Q4 | $113M | Sell |
1,331,756
-149,128
| -10% | -$11.8M | 0.84% | 13 |
|
|
2013
Q3 | $114M | Sell |
1,480,884
-197,610
| -12% | -$13.8M | 0.86% | 13 |
|
|
2013
Q2 | $98.1M | Buy |
+1,678,494
| New | +$101M | 0.73% | 24 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
BNP Paribas Asset Management's CELG Position: Q4 2019 in Review
BNP Paribas Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 269,518 shares — an estimated $26.8M sold.
BNP Paribas Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $151M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- BNP Paribas Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- BNP Paribas Asset Management sold 269,518 Celgene Corp shares in Q4 2019, an estimated $26.8M.
- BNP Paribas Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- BNP Paribas Asset Management's Celgene Corp position peaked at $151M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on BNP Paribas Asset Management's 13F filing for Q4 2019, filed 11 Feb 2020.